Cargando…
Mechanical phenotyping reveals unique biomechanical responses in retinoic acid-resistant acute promyelocytic leukemia
All-trans retinoic acid (ATRA) is an essential therapy in the treatment of acute promyelocytic leukemia (APL), but nearly 20% of patients with APL are resistant to ATRA. As there are no biomarkers for ATRA resistance that yet exist, we investigated whether cell mechanics could be associated with thi...
Autores principales: | Li, Brian, Maslan, Annie, Kitayama, Sean E., Pierce, Corinne, Streets, Aaron M., Sohn, Lydia L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8814755/ https://www.ncbi.nlm.nih.gov/pubmed/35141508 http://dx.doi.org/10.1016/j.isci.2022.103772 |
Ejemplares similares
-
Retinoic Acid and Arsenic for Treating Acute Promyelocytic Leukemia
por: Zhou, Guang-Biao, et al.
Publicado: (2005) -
Significance of ETV6 rearrangement in acute promyelocytic leukemia with t(15;17)/promyelocytic leukemia/retinoic acid receptor alpha
por: GAO, NA, et al.
Publicado: (2016) -
Dual origin of relapses in retinoic-acid resistant acute promyelocytic leukemia
por: Lehmann-Che, Jacqueline, et al.
Publicado: (2018) -
Oral arsenic and retinoic acid for high-risk acute promyelocytic leukemia
por: Ma, Ya-Fang, et al.
Publicado: (2022) -
Acute Myeloid Leukemia Acquiring Promyelocytic Leukemia-Retinoic Acid Receptor Alpha at Relapse
por: Gupta, Varsha, et al.
Publicado: (2019)